Modification of cellular ion transport by the Ha-ras oncogene: Steps towards malignant transformation

被引:37
|
作者
Ritter, M
Woll, E
机构
[1] Department of Internal Medicine, University oflnnsbruck
关键词
ras oncogene; intracellular calcium; calcium oscillations; intracellular pH; Na+/H+ exchanger; cell volume; ion channels; actin cytoskeleton;
D O I
10.1159/000154827
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression of the transforming Ha-ras oncogene in NIH 3T3 fibroblasts (+ras cells) results in growth-factor-independent proliferation, breakdown of actin stress fiber network and increase in intracellular pH and cell volume due to activation of the Na+/H+ exchanger and Na+, K+, 2Cl(-) cotransport. +ras cells respond to mitogens like serum or bradykinin with sustained oscillations of the cell membrane potential due to stimulated calcium entry which triggers pulsatile release of calcium from internal stores and subsequent activation of calcium-sensitive K+ channels. Calcium antagonists like bepridil or nifedipine inhibit cellular calcium entry and oscillations of the intracellular calcium concentration, protect +ras cells against actin stress fiber depolymerization, block activation of the Na+/H+ exchanger and inhibit cell proliferation. Inhibition of the Na+/H+ exchanger inhibits the increase in the intracellular pH and cell proliferation but does not alter cytoskeletal rearrangement, calcium entry or oscillations of intracellular calcium. In cells not expressing the oncogene (-ras cells), bradykinin causes a single transient hyperpolarization, is without effect on cytoarchitecture and leads to cell shrinkage unless actin filament disruption is induced by cytochalasin D or pretreatment of the cells with LiCl. Apparently the oscillations of intracellular calcium are required for depolymerization of the actin filaments and for activation of the Na+/H+ exchanger. Thus the alterations of ion transport are prerequisites for growth-factor-independent proliferation of Ha-ras-oncogene-expressing cells.
引用
收藏
页码:245 / 270
页数:26
相关论文
共 50 条
  • [1] CORRELATION BETWEEN TRANSFORMATION BY THE ACTIVATED CELLULAR ONCOGENE HA-RAS AND ACQUISITION OF METHIONINE-DEPENDENCE
    VANHAMME, L
    SZPIRER, C
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1986, 94 (01): : B57 - B57
  • [2] TRANSFORMATION OF NORMAL HOMOLOGOUS CELLS BY A SPONTANEOUSLY ACTIVATED HA-RAS ONCOGENE
    SCHWARTZ, SA
    SHULER, CF
    FREEBECK, P
    CANCER RESEARCH, 1988, 48 (12) : 3470 - 3477
  • [3] HA-RAS ONCOGENE EXPRESSION IN NON-MALIGNANT HUMAN-BREAST
    HILDEBRANDT, R
    LONGACRE, T
    WILLMAN, C
    BARTOW, S
    MODERN PATHOLOGY, 1988, 1 (01) : A39 - A39
  • [4] HA-RAS ONCOGENE EXPRESSION IN NON-MALIGNANT HUMAN-BREAST
    HILDEBRANDT, R
    LONGACRE, T
    WILLMAN, C
    BARTOW, S
    LABORATORY INVESTIGATION, 1988, 58 (01) : A39 - A39
  • [5] THE ROLE OF THE HA-RAS ONCOGENE IN MALIGNANT TRANSFORMATION OF NORMAL AND 2 ESTABLISHED CELL-LINES OF HUMAN KERATINOCYTES
    BOUKAMP, P
    STANBRIDGE, EJ
    CERUTTI, PA
    FUSENIG, NE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 146 - 146
  • [6] Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts
    Fürst, J
    Haller, T
    Chwatal, S
    Wöll, E
    Dartsch, PC
    Gschwentner, M
    Dienstl, A
    Zwierzina, H
    Lang, F
    Paulmichl, M
    Ritter, M
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2002, 12 (01) : 19 - 30
  • [7] COOPERATION BETWEEN BOVINE LEUKEMIA-VIRUS TRANSACTIVATOR PROTEIN AND HA-RAS ONCOGENE PRODUCT IN CELLULAR-TRANSFORMATION
    WILLEMS, L
    HEREMANS, H
    CHEN, G
    PORTETELLE, D
    BILLIAU, A
    BURNY, A
    KETTMANN, R
    EMBO JOURNAL, 1990, 9 (05): : 1577 - 1581
  • [8] PARTIAL TRANSFORMATION OF HUMAN THYROID EPITHELIAL-CELLS BY MUTANT HA-RAS ONCOGENE
    LEMOINE, NR
    STADDON, S
    BOND, J
    WYLLIE, FS
    SHAW, JJ
    WYNFORDTHOMAS, D
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A153 - A153
  • [9] PARTIAL TRANSFORMATION OF HUMAN THYROID EPITHELIAL-CELLS BY MUTANT HA-RAS ONCOGENE
    LEMOINE, NR
    STADDON, S
    BOND, J
    WYLLIE, FS
    SHAW, JJ
    WYNFORDTHOMAS, D
    ONCOGENE, 1990, 5 (12) : 1833 - 1837
  • [10] ALLELIC POLYMORPHISM OF HA-RAS ONCOGENE IN CHRONIC LEUKEMIA
    KNAUF, WU
    HO, AD
    SCHUTZ, V
    HUNSTEIN, W
    BLUT, 1986, 53 (03): : 151 - 151